|
Rakuno Gakuen Univ.
university of Naples Federico II EA Pharma Co.,Ltd. Rakuno Gakuen University Clemson University York University ITESM – ITE430714KI0 Loughborough University VIVEXIA University of Bath Clean Cells Biophage Pharma SA APC Microbiome Ireland, University College Cork Yale University The University of Adelaide Cellabs Pty Ltd Gothenburg University University of Gothenburg Dopharma Research University of Alabama Jichi Medical University Sree Balaji Medical College and Hospital, BIHER-Bharath University Fudan University LabMicta PTC Phage Technology Center GmbH
Phico Therapeutics Limited
University of Wisconsin-Madison
Naval Medical Research Center
University of Ferrara
University of Patras
University of Liege – ULg – Gembloux Agro-Bio Tech
Norwegian University of Life Sciences
University of Lausanne
Intralytix
Emergent Biosolutions IIBR Bose Institute Animal & Plant Health Agency Davolterra MaaT Pharma Guild BioSciences JSC “SIC”Microgen” Vésale Pharma Beiersdorf AG AiCuris JAFRAL BiomX Ltd. Phico Therapeutics Ltd MB Pharma |
Loughborough University University of Copenhagen |
NYU School of Medicine |
More than 150 international attendees are already registered for Phage Therapy & Antibiotic Resistance 2018
The 5th World Congress on Targeting Infectious Diseases – Phage Therapy & Antibiotic Resistance will gather more than 150 international attendees coming from industries, start-up and universities working on all infectious diseases related fields.
The audience of Phage Therapy 2018 will be composed by attendees coming from all around the world. Among the participants:
It is a non-exhaustive list of attendees, and we remind you that you can join all these leaders and save if you register before April 17, midnight by clicking here.
For more information: www.tid-site.com